
|Articles|July 11, 2014
Aesica Expands Oral Solids Capability at German Facility
Author(s)BioPharm International Editors
Aesica adds roller compaction unit for dry granulation production.
Advertisement
The new roller compaction unit uses a continuous production step that enhances product uniformity and has been undertaken following a market demand for pharmaceutical formulation technologies that enable the formulation of APIs otherwise inhibited by the presence of water.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
Bio/pharma Manufacturing Professionals Are Staying Put Despite Growing Uncertainty
3
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
4
Green Chemistry’s Role in Advancing US Chemical Innovation
5




